Scientists have developed a two-drug combination which has shown ecouraging in slowing down the progression of advanced melanoma. The combination of drugs targets different points in the same growth-factor pathway. This combination showed a postponement of 4 months. The study was carried out on 162 patients at 14 locations in the United States and Australia and after 1 year, 41% of patients receiving the full dose had no progression of their melanoma.
Further studies are taking place over a larger group of patients, which is needed for FDA approval in the States. People with fair skin are more likely to get skin cancers but all skin types can affect anyone. If you have a mole that starts to itch or there is a change in shape or size check with your doctor straight away. Please read for more information on moles,